ROLE OF MHC GENES IN IMMUNOREGULATION
ROLE OF MHC GENES IN IMMUNOREGULATION
批准号:
3125600
负责人:
JUDITH A KAPP
金额:
$17.71万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-01-01 至 1993-11-30
关键词:
antigen presenting cell apoptosis clone cells cytotoxic T lymphocyte gene expression genetic promoter element genetically modified animals helper T lymphocyte human genetic material tag hybridomas immune tolerance /unresponsiveness immunoregulation insulin insulin sensitivity /resistance laboratory mouse major histocompatibility complex metallothionein pancreatic islets suppressor T lymphocyte thymus
中文摘要
胸腺克隆缺失是T细胞
英文摘要
Clonal deletion in the thymus is the mechanism by which T cells
recognizing autologous autologous MHC class II antigens, Mls antigens,
and the male H-Y antigen are regulated. However, our studies of
transgenic mice expressing physiological levels of human insulin
indicate that tolerance is not maintained by clonal deletion. These
observations support the idea that additional mechanisms operate in the
peripheral immune system to maintain unresponsiveness of autoreactive T
cells not deleted in the thymus.
Using transgenic mice expressing the human insulin gene, we will dissect
the mechanisms that maintain peripheral tolerance. To this end, we will
determine: 1) whether insulin-specific Th cells are anergic in
transgenic mice; 2) the role of Ts cells in tolerance expressed by
transgenic mice; 3) whether human insulin-specific CTL can be stimulated
in transgenic recipients of nontransgenic T cells; and, 4) if there is
evidence for clonal deletion of high avidity T cells in transgenic mice.
The second goal of this project is to determine why clonal deletion in
the thymus is not effective for circulating autoantigens such as
insulin. We hypothesize that clonal deletion of T cells in the thymus
is antigen dose-dependent and that the concentration of insulin which
reaches the thymus in these transgenic mice is insufficient to cause
clonal deletion. A prediction of this hypothesis is that increasing the
levels of insulin in the circulation will result in clonal deletion of
human insulin-specific T cells. This will be assessed using transgenic
mice expressing human insulin under the regulation of the
metallothionein promoter or the I-E alpha promoter.
The lessons learned from these studies may provide new approaches to the
treatment of autoimmune diseases. Thus, our studies will be extended to
an immunological disease model of Experimental Allergic
Encephalomyelitis (EAE). This system will be used to address the
circumstances in which peripheral mechanisms of maintaining
self-tolerance fail and whether regulation can be re-instated once the
disease occurs.
These model systems are particularly relevant for the understanding of
autoimune diseases in man in which there is evidence that auto-reactive
T cells, present in the peripheral immune system, can escape from the
normal regulatory mechanisms.
Accumulating evidence suggests that autoimmunity may be involved in the
pathogenesis of AIDS. Thus, our studies may be relevant toward
understanding the immune dysfunction operating in AIDS and lead to the
designing of therapeutic approaches for its treatment.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
1984
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Robbins,PF, Thomas,JW, Jensen,PE, Kapp,JA]
通讯作者:
Kapp,JA
Comparison of the T cell receptors on insulin-specific hybridomas from insulin transgenic and nontransgenic mice. Loss of a subpopulation of self-reactive clones.
胰岛素转基因和非转基因小鼠胰岛素特异性杂交瘤上 T 细胞受体的比较。
DOI:
--
发表时间:
1992
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Poindexter,NJ, Landon,C, Whiteley,PJ, Kapp,JA]
通讯作者:
Kapp,JA
Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells.
口服抗原抑制 CD8 CTL、CD4 T 细胞和抗体反应的启动,同时激活 CD8 抑制性 T 细胞。
DOI:
--
发表时间:
1996
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Ke,Y, Kapp,JA]
通讯作者:
Kapp,JA
DOI:
--
发表时间:
1994
期刊:
Archivum immunologiae et therapiae experimentalis
影响因子:
3.2
作者:
[Zimecki,M, Kapp,JA]
通讯作者:
Kapp,JA
DOI:
10.1084/jem.160.4.1012
发表时间:
1984-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Jensen PE, Pierce CW, Kapp JA]
通讯作者:
Kapp JA
共 47 条
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:7068479
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:6912734
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:6789520
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Retinal Cell Transplantation Tolerance and Rejection
-
批准号:7235606
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2004
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6635735
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6318736
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6518724
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
Regulation of Ocular Tolerance by Gamma/delta T Cells
-
批准号:6896318
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:6376248
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2114274
-
项目类别:
-
资助金额:$23.08万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2700672
-
项目类别:
-
资助金额:$24.31万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:6173216
-
项目类别:
-
资助金额:$23.61万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2848368
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
GAMMA/DELTA T CELLS IN TOLERANCE AND TUMOR IMMUNITY
-
批准号:2414453
-
项目类别:
-
资助金额:$23.68万
-
财政年份:1996
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNOREGULATION
-
批准号:2060027
-
项目类别:
-
资助金额:$12.44万
-
财政年份:1993
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNOREGULATION
-
批准号:3125599
-
项目类别:
-
资助金额:$8.3万
-
财政年份:1992
-
负责人:JUDITH A KAPP
-
依托单位:
STRUCTURE AND EXPRESSION OF SUPPRESSOR T CELL PRODUCTS
-
批准号:3128366
-
项目类别:
-
资助金额:$29.35万
-
财政年份:1982
-
负责人:JUDITH A KAPP
-
依托单位:
STRUCTURE AND EXPRESSION OF SUPPRESSOR T CELL PRODUCTS
-
批准号:3128367
-
项目类别:
-
资助金额:$28.14万
-
财政年份:1982
-
负责人:JUDITH A KAPP
-
依托单位:
ROLE OF MHC GENES IN IMMUNREGULATION
-
批准号:3125591
-
项目类别:
-
资助金额:$18.04万
-
财政年份:1977
-
负责人:JUDITH A KAPP
-
依托单位:
MODE OF ACTION OF H-LINKED IMMUNE RESPONSE (IR) GENES
-
批准号:3125595
-
项目类别:
-
资助金额:$19.9万
-
财政年份:1977
-
负责人:JUDITH A KAPP
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: